Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs

Fraser Coxon, H L Benford, Graham G Russell, Michael John Rogers

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The exact mechanisms of action of antiresorptive bisphosphonate drugs remain unclear, although they may inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis. These drugs also cause apoptosis in J774 macrophages, probably as a consequence of inhibition of protein prenylation. However, the molecular pathways that lead to apoptosis are not known. In some cells, apoptosis induced by statins (other inhibitors of protein prenylation) is dependent on protein synthesis. The aim of this study was to further characterize the kinetics and biochemical features of bisphosphonate-induced apoptosis, including the dependence on protein synthesis. Alendronate-induced apoptosis in J774 cells occurred after approximately 16 hr of treatment, although shorter exposures to the drug followed by incubation in bisphosphonate-free medium also committed cells to apoptosis. The appearance of apoptotic cells was associated with the appearance of caspase-3-like activity. Apoptosis induced by bisphosphonate or mevastatin was found to be dependent on protein synthesis because cycloheximide inhibited chromatin condensation, DNA fragmentation and activation of caspase-3-like protease or proteases. Protein synthesis was required for events that lead to commitment to apoptosis but not for the execution phase because cycloheximide did not prevent apoptosis when added >/=15 hr after the start of alendronate treatment. Furthermore, staurosporine-induced caspase-3-like activity and apoptosis in J774 cells could not be prevented by cycloheximide. These observations demonstrate that activation of caspase-3-like proteases and inhibition of commitment to apoptosis by cycloheximide are common features of apoptotic cell death induced by inhibitors of protein prenylation such as bisphosphonates.
Original languageEnglish
Pages (from-to)631-638
Number of pages8
JournalMolecular Pharmacology
Volume54
Issue number4
Publication statusPublished - 1 Oct 1998

Fingerprint

Diphosphonates
Caspases
Apoptosis
Pharmaceutical Preparations
Proteins
Protein Prenylation
Cycloheximide
Caspase 3
Alendronate
Peptide Hydrolases
Bone Density Conservation Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Staurosporine
Osteoclasts
DNA Fragmentation
Bone Resorption
Chromatin
Cell Death
Macrophages

Keywords

  • Alendronate
  • Animals
  • Apoptosis
  • Carbon Radioisotopes
  • Caspase 3
  • Caspases
  • Cell Line
  • Cycloheximide
  • Diphosphonates
  • Enzyme Activation
  • Enzyme Inhibitors
  • Lovastatin
  • Macrophages
  • Mevalonic Acid
  • Mice
  • Protein Biosynthesis
  • Protein Synthesis Inhibitors

Cite this

Coxon, F., Benford, H. L., Russell, G. G., & Rogers, M. J. (1998). Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Molecular Pharmacology, 54(4), 631-638.

Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. / Coxon, Fraser; Benford, H L; Russell, Graham G; Rogers, Michael John.

In: Molecular Pharmacology, Vol. 54, No. 4, 01.10.1998, p. 631-638.

Research output: Contribution to journalArticle

Coxon, F, Benford, HL, Russell, GG & Rogers, MJ 1998, 'Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs', Molecular Pharmacology, vol. 54, no. 4, pp. 631-638.
Coxon, Fraser ; Benford, H L ; Russell, Graham G ; Rogers, Michael John. / Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. In: Molecular Pharmacology. 1998 ; Vol. 54, No. 4. pp. 631-638.
@article{a5cff33a469542d899fc4afdcad45c22,
title = "Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs",
abstract = "The exact mechanisms of action of antiresorptive bisphosphonate drugs remain unclear, although they may inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis. These drugs also cause apoptosis in J774 macrophages, probably as a consequence of inhibition of protein prenylation. However, the molecular pathways that lead to apoptosis are not known. In some cells, apoptosis induced by statins (other inhibitors of protein prenylation) is dependent on protein synthesis. The aim of this study was to further characterize the kinetics and biochemical features of bisphosphonate-induced apoptosis, including the dependence on protein synthesis. Alendronate-induced apoptosis in J774 cells occurred after approximately 16 hr of treatment, although shorter exposures to the drug followed by incubation in bisphosphonate-free medium also committed cells to apoptosis. The appearance of apoptotic cells was associated with the appearance of caspase-3-like activity. Apoptosis induced by bisphosphonate or mevastatin was found to be dependent on protein synthesis because cycloheximide inhibited chromatin condensation, DNA fragmentation and activation of caspase-3-like protease or proteases. Protein synthesis was required for events that lead to commitment to apoptosis but not for the execution phase because cycloheximide did not prevent apoptosis when added >/=15 hr after the start of alendronate treatment. Furthermore, staurosporine-induced caspase-3-like activity and apoptosis in J774 cells could not be prevented by cycloheximide. These observations demonstrate that activation of caspase-3-like proteases and inhibition of commitment to apoptosis by cycloheximide are common features of apoptotic cell death induced by inhibitors of protein prenylation such as bisphosphonates.",
keywords = "Alendronate, Animals, Apoptosis, Carbon Radioisotopes, Caspase 3, Caspases, Cell Line, Cycloheximide, Diphosphonates, Enzyme Activation, Enzyme Inhibitors, Lovastatin, Macrophages, Mevalonic Acid, Mice, Protein Biosynthesis, Protein Synthesis Inhibitors",
author = "Fraser Coxon and Benford, {H L} and Russell, {Graham G} and Rogers, {Michael John}",
year = "1998",
month = "10",
day = "1",
language = "English",
volume = "54",
pages = "631--638",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS",
number = "4",

}

TY - JOUR

T1 - Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs

AU - Coxon, Fraser

AU - Benford, H L

AU - Russell, Graham G

AU - Rogers, Michael John

PY - 1998/10/1

Y1 - 1998/10/1

N2 - The exact mechanisms of action of antiresorptive bisphosphonate drugs remain unclear, although they may inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis. These drugs also cause apoptosis in J774 macrophages, probably as a consequence of inhibition of protein prenylation. However, the molecular pathways that lead to apoptosis are not known. In some cells, apoptosis induced by statins (other inhibitors of protein prenylation) is dependent on protein synthesis. The aim of this study was to further characterize the kinetics and biochemical features of bisphosphonate-induced apoptosis, including the dependence on protein synthesis. Alendronate-induced apoptosis in J774 cells occurred after approximately 16 hr of treatment, although shorter exposures to the drug followed by incubation in bisphosphonate-free medium also committed cells to apoptosis. The appearance of apoptotic cells was associated with the appearance of caspase-3-like activity. Apoptosis induced by bisphosphonate or mevastatin was found to be dependent on protein synthesis because cycloheximide inhibited chromatin condensation, DNA fragmentation and activation of caspase-3-like protease or proteases. Protein synthesis was required for events that lead to commitment to apoptosis but not for the execution phase because cycloheximide did not prevent apoptosis when added >/=15 hr after the start of alendronate treatment. Furthermore, staurosporine-induced caspase-3-like activity and apoptosis in J774 cells could not be prevented by cycloheximide. These observations demonstrate that activation of caspase-3-like proteases and inhibition of commitment to apoptosis by cycloheximide are common features of apoptotic cell death induced by inhibitors of protein prenylation such as bisphosphonates.

AB - The exact mechanisms of action of antiresorptive bisphosphonate drugs remain unclear, although they may inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis. These drugs also cause apoptosis in J774 macrophages, probably as a consequence of inhibition of protein prenylation. However, the molecular pathways that lead to apoptosis are not known. In some cells, apoptosis induced by statins (other inhibitors of protein prenylation) is dependent on protein synthesis. The aim of this study was to further characterize the kinetics and biochemical features of bisphosphonate-induced apoptosis, including the dependence on protein synthesis. Alendronate-induced apoptosis in J774 cells occurred after approximately 16 hr of treatment, although shorter exposures to the drug followed by incubation in bisphosphonate-free medium also committed cells to apoptosis. The appearance of apoptotic cells was associated with the appearance of caspase-3-like activity. Apoptosis induced by bisphosphonate or mevastatin was found to be dependent on protein synthesis because cycloheximide inhibited chromatin condensation, DNA fragmentation and activation of caspase-3-like protease or proteases. Protein synthesis was required for events that lead to commitment to apoptosis but not for the execution phase because cycloheximide did not prevent apoptosis when added >/=15 hr after the start of alendronate treatment. Furthermore, staurosporine-induced caspase-3-like activity and apoptosis in J774 cells could not be prevented by cycloheximide. These observations demonstrate that activation of caspase-3-like proteases and inhibition of commitment to apoptosis by cycloheximide are common features of apoptotic cell death induced by inhibitors of protein prenylation such as bisphosphonates.

KW - Alendronate

KW - Animals

KW - Apoptosis

KW - Carbon Radioisotopes

KW - Caspase 3

KW - Caspases

KW - Cell Line

KW - Cycloheximide

KW - Diphosphonates

KW - Enzyme Activation

KW - Enzyme Inhibitors

KW - Lovastatin

KW - Macrophages

KW - Mevalonic Acid

KW - Mice

KW - Protein Biosynthesis

KW - Protein Synthesis Inhibitors

M3 - Article

VL - 54

SP - 631

EP - 638

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -